Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Letters|January 8, 2025
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor modelUjjwol Khatri, Mohamed A Gouda, Shriya Pandey, et al.
Cell Reports. Medicine|December 20, 2023
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancersMirella Nardo, Mohamed A Gouda, Blessie E Nelson, et al.
Journal of Immunotherapy and Precision Oncology|January 16, 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B TrialMohamed A Gouda, Abdulrazzak Zarifa, Yali Yang, et al.
NPJ Precision Oncology|March 4, 2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancerVivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, et al.
Cancer Medicine|October 10, 2024
Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant MelanomaJiri Polivka, Mohamed A Gouda, Mahyar Sharif, et al.
Critical Reviews in Oncology/Hematology|May 30, 2025
Cancer in a drop: Advances in liquid biopsy in 2024Roberto Borea, Erick F Saldanha, Shivahamy Maheswaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
The Oncologist|October 6, 2022
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific SignaturesMohamed A Gouda, Dzifa Y Duose, Morten Lapin, et al.
JCO Precision Oncology|July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced CancersMohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
The Oncologist|September 20, 2022
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck CancerFaye M Johnson, Filip Janku, Mohamed A Gouda, et al.
Pageof 5